Quality assessment of systematic reviews for acupuncture to treat polycystic ovary syndrome_Chinese Journal of Evidence-Based Medicine

Authors：

XI Jin ¹ , CHEN Hao ¹ , CHENG Jie ¹ , MENG Qingyu ¹ ,  XIA Youbing ^1,2

1. the Second Clinical College, Nanjing University of Chinese Medicine, Nanjing, 210029, P.R.China;
2. Xuzhou Medical University, Xuzhou, 221004, P.R.China;

Corresponding?author：

XIA Youbing, Email: xybd1968@sina.com

Keywords：

Acupuncture; Polycystic ovary syndrome; Overview of systematic review; AMSTAR; GRADE system

DOI：

10.7507/1672-2531.201804201

Video：

Export PDF Favorites Scan Get Citation

Abstract Full text Figures/Tables Video References Cited by

Objectives To evaluate the methodological bias and the reliability of the conclusions of systematic reviews on acupuncture for polycystic ovary syndrome. Methods We comprehensively searched PubMed, EMbase, The Cochrane Library, CBM, CNKI and WanFang Data to collect systematic reviews on acupuncture for polycystic ovary syndrome from the establishment time of databases to January 5^th, 2018. The AMSTAR tool was applied for methodological quality assessment of included studies and the GRADE system was applied for evidence quality assessment of included outcomes of systematic reviews. Results A total of 11 systematic reviews were included. The results of assessment using AMSTAR showed that, among the 11 items, most problems occurred in Item 5 " Were there any lists of research articles included and excluded”, followed by Item 1" Was an‘a prior’design provided?”and Item 11" Were potential conflict of interest included?”. GRADE grading results showed that quality of evidence for the outcome measure were" low”or" very low”. Conclusions Current acupuncture treatment of polycystic ovary syndrome has a certain effect, however, the quality of evidence is low. Thus, physicians should apply the evidence to make decision on acupuncture for polycystic ovary syndrome with caution in clinical practice and consider the actual situation, combined with the patient’s value preferences and economic factors.

Citation： XI Jin, CHEN Hao, CHENG Jie, MENG Qingyu, XIA Youbing. Quality assessment of systematic reviews for acupuncture to treat polycystic ovary syndrome. Chinese Journal of Evidence-Based Medicine, 2019, 19(2): 205-211. doi: 10.7507/1672-2531.201804201 Copy

1.	Homburg R. Management of infertility and prevention of ovarian hyperstimulation in women with polycystic ovary syndrome. Best Pract Res Clin Obstet Gynaecol, 2004, 18(5): 773-788.
2.	Lizneva D, Suturina L, Walker W, et al. Criteria, prevalence, and phenotypes of polycystic ovary syndrome. Fertil Steril, 2016, 106(1): 6-15.
3.	Teede H, Deeks A, Moran L. Polycystic ovary syndrome: a complex condition with psychological, reproductive and metabolic manifestations that impacts on health across the lifespan. BMC Med, 2010, 8: 41.
4.	Jedel E, Waern M, Gustafson D, et al. Anxiety and depression symptoms in women with polycystic ovary syndrome compared with controls matched for body mass index. Human Reprod, 2010, 25(2): 450-456.
5.	Petta S, Ciresi A, Bianco J, et al. Insulin resistance and hyperandrogenism drive steatosis and fibrosis risk in young females with PCOS. Plos One, 2017, 12(11): e0186136.
6.	Ashrafi M, Sheikhan F, Arabipoor A, et al. Gestational diabetes mellitus and metabolic disorder among the different phenotypes of polycystic ovary syndrome. Oman Med J, 2017, 32(3): 214-220.
7.	Yu H, Chen H, Rao D, et al. Association between polycystic ovary syndrome and the risk of pregnancy complications: a PRISMA-compliant systematic review and meta-analysis. Medicine (Baltimore), 2016, 95(51): e4863.
8.	Costello MF, Misso ML, Wong J, et al. The treatment of infertility in polycystic ovary syndrome: a brief update. Aust N Z J Obstet Gynaecol, 2012, 52(4): 400-403.
9.	Cheragh E, Soleimani Mehranjani M, Shariatzadeh SMA, et al. N-Acetylcysteine compared to metformin, improves the expression profile of growth differentiation factor-9 and receptor tyrosine kinase c-kit in the oocytes of patients with polycystic ovarian syndrome. Int J Fertil Steril, 2018, 11(4): 270-278.
10.	de Medeiros SF. Risks, benefits size and clinical implications of combined oral contraceptive use in women with polycystic ovary syndrome. Reprod Biol Endocrinol, 2017, 15(1): 93.
11.	Johansson J, Stener-Victorin E. Polycystic ovary syndrome: effect and mechanisms of acupuncture for ovulation induction. Evid Based Complement Alternat Med, 2013, 2013: 762615.
12.	高金金, 侯麗輝, 李妍. 多囊卵巢綜合征的病理機制和針刺治療機制的研究進展. 中華中醫藥學刊, 2016, 34(2): 320-323.
13.	熊俊, 陳日新. 系統評價/Meta 分析方法學質量的評價工具 AMSTAR. 中國循證醫學雜志, 2011, 11(9): 1084-1089.
14.	Guyatt GH, Oxman AD, Vist GE, et al. GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ, 2008, 336(7650): 924-926.
15.	任麗娜, 郭麗紅, 馬文珠, 等. 針刺治療多囊卵巢綜合征: 隨機對照試驗的系統綜述和 Meta 分析. 針刺研究, 2014, 39(3): 238-246.
16.	馬紅. 針刺治療多囊卵巢綜合征及其改善焦慮狀態的研究. 廣東: 廣州中醫藥大學, 2014.
17.	朱怡, 沈衛東. 針灸與西藥治療多囊卵巢綜合征療效比較的 Meta 分析. 中醫學報, 2014, 29(11): 1649-1652.
18.	林可. 針灸治療多囊卵巢綜合征的 Meta 分析. 廣東: 廣州中醫藥大學, 2013.
19.	張戈. 針灸治療多囊卵巢綜合征所致不孕的薈萃分析. 哈爾濱: 黑龍江中醫藥大學, 2011.
20.	李瑞根, 王威, 許曉蓓, 等. 針藥并用治療多囊卵巢綜合征療效系統綜述與 Meta 分析. 實用中醫內科雜志, 2016, 30(1): 1-5.
21.	錢麗歡. 針灸治療多囊卵巢綜合征的現代中文期刊文獻研究. 廣東: 廣州中醫藥大學, 2016.
22.	Lim CE, Ng RW, Xu K, et al. Acupuncture for polycystic ovarian syndrome. Cochrane Database Syst Rev, 2016, (5): CD007689.
23.	Jo J, Lee YJ, Lee H. Acupuncture for polycystic ovarian syndrome: a systematic review and meta-analysis. Medicine (Baltimore), 2017, 96(23): e7066.
24.	Qu F, Wu Y, Hu XY, et al. The effects of acupuncture on polycystic ovary syndrome: a systematic review and meta-analysis. Eur J Integr Med, 2016, 8(1): 12-18.
25.	余超超, 馬朝陽, 熊袁, 等. 穴位埋線治療多囊卵巢綜合征的系統評價和 Meta 分析. WJAM, 2017, 27(4): 41-51.
26.	Booth A, Clarke M, Ghersi D, et al. An international registry of systematic-reviews protocols. Lancet, 2011, 377(9760): 108-109.
27.	郭新峰, 賴世隆, 梁偉雄. 中醫藥臨床療效評價中結局指標的選擇與應用. 廣州中醫藥大學學報, 2002, 19(4): 251-255.
28.	薛春芬, 陳蓮萍. 多囊卵巢綜合征的藥物治療進展. 醫學綜述, 2018, 24(1): 144-149.
29.	郭磊. 不同藥物預處理多囊卵巢綜合征合并不孕患者的療效及不良反應觀察. 吉林醫學, 2017, 38(11): 2095-2096.
30.	Lanham MS, Lebovic DI, Domino SE. Contemporary medical therapy for polycystic ovary syndrome. Int J Gynaecol Obstet, 2006, 95(3): 236-241.

1. Homburg R. Management of infertility and prevention of ovarian hyperstimulation in women with polycystic ovary syndrome. Best Pract Res Clin Obstet Gynaecol, 2004, 18(5): 773-788.
2. Lizneva D, Suturina L, Walker W, et al. Criteria, prevalence, and phenotypes of polycystic ovary syndrome. Fertil Steril, 2016, 106(1): 6-15.
3. Teede H, Deeks A, Moran L. Polycystic ovary syndrome: a complex condition with psychological, reproductive and metabolic manifestations that impacts on health across the lifespan. BMC Med, 2010, 8: 41.
4. Jedel E, Waern M, Gustafson D, et al. Anxiety and depression symptoms in women with polycystic ovary syndrome compared with controls matched for body mass index. Human Reprod, 2010, 25(2): 450-456.
5. Petta S, Ciresi A, Bianco J, et al. Insulin resistance and hyperandrogenism drive steatosis and fibrosis risk in young females with PCOS. Plos One, 2017, 12(11): e0186136.
6. Ashrafi M, Sheikhan F, Arabipoor A, et al. Gestational diabetes mellitus and metabolic disorder among the different phenotypes of polycystic ovary syndrome. Oman Med J, 2017, 32(3): 214-220.
7. Yu H, Chen H, Rao D, et al. Association between polycystic ovary syndrome and the risk of pregnancy complications: a PRISMA-compliant systematic review and meta-analysis. Medicine (Baltimore), 2016, 95(51): e4863.
8. Costello MF, Misso ML, Wong J, et al. The treatment of infertility in polycystic ovary syndrome: a brief update. Aust N Z J Obstet Gynaecol, 2012, 52(4): 400-403.
9. Cheragh E, Soleimani Mehranjani M, Shariatzadeh SMA, et al. N-Acetylcysteine compared to metformin, improves the expression profile of growth differentiation factor-9 and receptor tyrosine kinase c-kit in the oocytes of patients with polycystic ovarian syndrome. Int J Fertil Steril, 2018, 11(4): 270-278.
10. de Medeiros SF. Risks, benefits size and clinical implications of combined oral contraceptive use in women with polycystic ovary syndrome. Reprod Biol Endocrinol, 2017, 15(1): 93.
11. Johansson J, Stener-Victorin E. Polycystic ovary syndrome: effect and mechanisms of acupuncture for ovulation induction. Evid Based Complement Alternat Med, 2013, 2013: 762615.
12. 高金金, 侯麗輝, 李妍. 多囊卵巢綜合征的病理機制和針刺治療機制的研究進展. 中華中醫藥學刊, 2016, 34(2): 320-323.
13. 熊俊, 陳日新. 系統評價/Meta 分析方法學質量的評價工具 AMSTAR. 中國循證醫學雜志, 2011, 11(9): 1084-1089.
14. Guyatt GH, Oxman AD, Vist GE, et al. GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ, 2008, 336(7650): 924-926.
15. 任麗娜, 郭麗紅, 馬文珠, 等. 針刺治療多囊卵巢綜合征: 隨機對照試驗的系統綜述和 Meta 分析. 針刺研究, 2014, 39(3): 238-246.
16. 馬紅. 針刺治療多囊卵巢綜合征及其改善焦慮狀態的研究. 廣東: 廣州中醫藥大學, 2014.
17. 朱怡, 沈衛東. 針灸與西藥治療多囊卵巢綜合征療效比較的 Meta 分析. 中醫學報, 2014, 29(11): 1649-1652.
18. 林可. 針灸治療多囊卵巢綜合征的 Meta 分析. 廣東: 廣州中醫藥大學, 2013.
19. 張戈. 針灸治療多囊卵巢綜合征所致不孕的薈萃分析. 哈爾濱: 黑龍江中醫藥大學, 2011.
20. 李瑞根, 王威, 許曉蓓, 等. 針藥并用治療多囊卵巢綜合征療效系統綜述與 Meta 分析. 實用中醫內科雜志, 2016, 30(1): 1-5.
21. 錢麗歡. 針灸治療多囊卵巢綜合征的現代中文期刊文獻研究. 廣東: 廣州中醫藥大學, 2016.
22. Lim CE, Ng RW, Xu K, et al. Acupuncture for polycystic ovarian syndrome. Cochrane Database Syst Rev, 2016, (5): CD007689.
23. Jo J, Lee YJ, Lee H. Acupuncture for polycystic ovarian syndrome: a systematic review and meta-analysis. Medicine (Baltimore), 2017, 96(23): e7066.
24. Qu F, Wu Y, Hu XY, et al. The effects of acupuncture on polycystic ovary syndrome: a systematic review and meta-analysis. Eur J Integr Med, 2016, 8(1): 12-18.
25. 余超超, 馬朝陽, 熊袁, 等. 穴位埋線治療多囊卵巢綜合征的系統評價和 Meta 分析. WJAM, 2017, 27(4): 41-51.
26. Booth A, Clarke M, Ghersi D, et al. An international registry of systematic-reviews protocols. Lancet, 2011, 377(9760): 108-109.
27. 郭新峰, 賴世隆, 梁偉雄. 中醫藥臨床療效評價中結局指標的選擇與應用. 廣州中醫藥大學學報, 2002, 19(4): 251-255.
28. 薛春芬, 陳蓮萍. 多囊卵巢綜合征的藥物治療進展. 醫學綜述, 2018, 24(1): 144-149.
29. 郭磊. 不同藥物預處理多囊卵巢綜合征合并不孕患者的療效及不良反應觀察. 吉林醫學, 2017, 38(11): 2095-2096.
30. Lanham MS, Lebovic DI, Domino SE. Contemporary medical therapy for polycystic ovary syndrome. Int J Gynaecol Obstet, 2006, 95(3): 236-241.

Previous Article
Quality assessment of Chinese clinical practice guidelines for diagnosis and management of atrial fibrillation
Next Article
The overview of pharmacoeconomic systematic reviews

Chinese Journal of Evidence-Based Medicine

Quality assessment of systematic reviews for acupuncture to treat polycystic ovary syndrome

Abstract Full text Figures/Tables Video References Cited by

Previous Article

Next Article

Format

Content